Home Contact Sitemap

PedAM

Pediatric Disease Annotations & Medicines




Disease vascular disease
Phenotype C0022661|chronic kidney disease
Sentences 122
PubMedID- 23745333 Some studies showed correlation between the elevated fgf-23 level and increased mortality from cardiovascular disease in patients with chronic kidney disease.
PubMedID- 22269967 Diagnosis of cardiovascular disease in patients with chronic kidney disease.
PubMedID- 22943818 [the current situation and thoughts of cardiovascular disease in chronic kidney disease].
PubMedID- 21288351 The risk of cardiovascular disease is elevated in patients with chronic kidney disease (ckd) with an inverse graded relationship to glomerular filtration rate (gfr) independent of other risk factors [1].
PubMedID- 26236158 Anemia is an independent risk factor for development of cardiovascular diseases in patients with chronic kidney disease.
PubMedID- 25093403 Low-dose aspirin for prevention of cardiovascular disease in patients with chronic kidney disease.
PubMedID- 24231387 The age-rage pathway and its relation to cardiovascular disease in patients with chronic kidney disease.
PubMedID- 21448530 [assessment and management of cardiovascular disease in patients with chronic kidney disease].
PubMedID- 25018979 chronic kidney disease, prevalence of premature cardiovascular disease, and relationship to short-term mortality.
PubMedID- 21529268 Associations of plasma pentraxin 3 and monocyte chemoattractant protein-1 concentrations with cardiovascular disease in patients with chronic kidney disease.
PubMedID- 21562144 Background: markers of collagen turnover have not been well studied in the context of cardiovascular disease in patients with chronic kidney disease (ckd).
PubMedID- 24441913 Aim: vascular calcification, an independent risk factor for cardiovascular disease in patients with chronic kidney disease(ckd), refers to the mineralization of vascular smooth muscle cells(vsmcs) caused by phenotypic changes toward osteoblast-like cells.
PubMedID- 22749861 Aims: proteinuria is an independent risk factor for cardiovascular disease (cvd) in patients with chronic kidney disease (ckd).
PubMedID- 21750584 Cardiovascular disease in chronic kidney disease.
PubMedID- 21331317 Cardiorenal syndrome type 4-cardiovascular disease in patients with chronic kidney disease: epidemiology, pathogenesis, and management.
PubMedID- 22214476 Management of cardiovascular disease in chronic kidney disease: implications for managed care.
PubMedID- 20884698 Objective: to quantify associations of chronic kidney disease stages with major cardiovascular disease and non-vascular mortality in the general adult population.
PubMedID- 26264647 Type 4 cardiorenal syndrome (crs) is a life-threatening world health problem in which chronic kidney disease leads to progressive cardiovascular disease.
PubMedID- 20586902 Screening for cardiovascular disease in patients with advanced chronic kidney disease.
PubMedID- 21647319 Vitamin d deficiency appears to be an underestimated risk factor for cardiovascular disease in patients with chronic kidney disease.
PubMedID- 21063202 Background and objective: whether treatment with vitamin d receptor activators contributes to cardiovascular disease in patients with chronic kidney disease is a matter of debate.
PubMedID- 24129557 Lipoprotein(a) is one of the strongest genetically determined risk factors for cardiovascular disease, and patients with chronic kidney disease have major disturbances in lipoprotein(a) metabolism.
PubMedID- 21541471 Assessment and management of cardiovascular disease in patients with chronic kidney disease.
PubMedID- 25030514 Stroke and cerebrovascular diseases in patients with chronic kidney disease.
PubMedID- 24157604 Exciting new discoveries have highlighted fgf-23 as an independent risk factor for cardiovascular disease in patients with chronic kidney disease.
PubMedID- 22780692 Cardiovascular disease in chronic kidney disease: untying the gordian knot.
PubMedID- 26354563 The objective of this study is to determine the prevalence of peripheral vascular disease (pvd) in patients with chronic kidney disease (ckd).
PubMedID- 26500541 The patient was known to have longstanding hypertension with stage 2 chronic kidney disease due to hypertensive/vascular disease.
PubMedID- 24766515 Cdata adjusted for age, sex, dyslipidemia, diabetes mellitus, chronic kidney disease, history of cardiovascular disease, and changes in the number and dose of antihypertensive drugs (other than olmesartan) during the 16-week follow-up period.
PubMedID- 22470397 Proteinuria is an important risk factor not only for progression of renal failure but also for the development of cardiovascular disease in patients with chronic kidney disease (ckd) [17].
PubMedID- 23206977 Accelerated atherosclerosis and arterial stiffness are the two leading causes of increased cardiovascular disease in patients with chronic kidney disease.
PubMedID- 21876352 Background: cardiovascular disease in chronic kidney disease (ckd) has peculiar characteristics.
PubMedID- 21420113 Long-term prospective studies and closer followup of donors are needed to identify its implications, given the associated risk of cardiovascular diseases with chronic kidney disease in the general population.
PubMedID- 26133318 Association between ophthalmological changes and cardiovascular diseases in patients with chronic kidney disease undergoing hemodialysis.
PubMedID- 26037625 Earlier reports confirmed the association of cca-imt with coronary artery calcium score (cacs) and cardiovascular disease not only in patients with chronic kidney disease [10] but also in patients with diabetes type 2 [22] and rheumatoid arthritis [27].
PubMedID- 25874808 Discussion: given the high burden of cardiovascular disease in women with chronic kidney disease, this study will help guide clinical practice by summarizing current evidence on the use of hormone therapy for prevention of all-cause mortality, cardiovascular mortality, and cardiovascular morbidity in this population.
PubMedID- 26430136 Renovascular disease (rvd) can lead to hypertension and chronic kidney disease (ckd).
PubMedID- 25550968 Asymmetric dimethylarginine (adma) has been involved in the development mechanism of cardiovascular disease (cvd) in patients with chronic kidney disease.
PubMedID- 22629024 Risk factors of cardiovascular disease among children with chronic kidney disease in gaza strip.
PubMedID- 24055267 Background and aims: p-cresyl sulfate (pcs) and indoxyl sulfate (is) were not only novel but essential factors associated with cardiovascular disease and mortality in patients with chronic kidney disease and hemodialysis.
PubMedID- 26426087 Plasma xanthine oxidase activity is predictive of cardiovascular disease in patients with chronic kidney disease, independently of uric acid levels.
PubMedID- 26374599 Insulin resistance (ir) is a novel cardiovascular risk factor that has been implicated in the pathogenesis of cardiovascular disease (cvd) in patients with chronic kidney disease (ckd).
PubMedID- 26312829 Background: hyperphosphataemia is a risk factor for accelerated cardiovascular disease in chronic kidney disease.
PubMedID- 23120811 High incidence of cardiovascular diseases in patients with chronic kidney disease (ckd) can not soley be explained by traditional risk factors.
PubMedID- 25830914 In this pilot study transcriptome analysis of peripheral blood monocytes was used to identify in an unprejudiced manner which factors could be discriminative for cardiovascular disease in patients with chronic kidney disease on hemodialysis.
PubMedID- 25874106 Therefore, hyperphosphataemia is a widely recognized risk factor for mortality and cardiovascular disease in patients with chronic kidney disease (ckd) [1].
PubMedID- 23451044 The high prevalence of cardiovascular disease in chronic kidney disease (ckd) stage 5 d, i.e.
PubMedID- 21556311 Target diseases were knee and/or hip osteoarthritis, poliomyelitis, chronic kidney disease, discomforts of pregnancy, cardiovascular diseases, and rotator cuff tears.
PubMedID- 23113674 Aim: the current data have proven the pivotal role of inflammation in the development of atherosclerosis and cardiovascular diseases in patients with chronic kidney disease (ckd).
PubMedID- 20884696 As stroke is a leading cause of mortality and morbidity worldwide, and several strategies, such as blood pressure control and use of statins and aspirin, may reduce subsequent cardiovascular disease in patients with chronic kidney disease, it is important to identify people at potential high risk, then appropriate therapy can be applied.7 8 we carried out a systematic review and meta-analysis to determine whether a link exists between reduced egfr and incident stroke and the magnitude of any relation.

Page: 1 2 3